Form 4: Essa Pharma Director Acquires 50,000 Options

John Alexander Martin, a director of Essa Pharma Inc., acquired 50,000 options exercisable for common shares on March 25, 2024.

Summary

• On March 25, 2024, John Alexander Martin, a director of Essa Pharma Inc., acquired 50,000 options.
• The options have an exercise price of $9.04.
• The options become exercisable on March 25, 2025, and expire on March 25, 2034.
• Following the transaction, Martin directly owns 50,000 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

This filing is a routine disclosure of a company director's stock option acquisition, which is a common practice in publicly traded companies to align management's interests with those of the shareholders.

Stakeholder Impact

• The acquisition of options by a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.

Key Dates